Similarly, lobaplatin promotes apoptosis and inhibits the proliferation of HCC by upregulating the PERK-eIF2α-ATF4-CHOP pathway (Li et al., 2019). This evidence concerns the gene ATF4 and hepatocellular carcinoma.